Anxiety, defence and the elevated plus-maze

https://doi.org/10.1016/S0149-7634(96)00058-9Get rights and content

Abstract

The elevated plus-maze test has been in use as a rodent model of anxiety for a decade, and is representative of those tests that are based upon the study of spontaneous behaviour patterns and which ave high ecological validity. The origins of the test in studies of the relationship between exploration and fear are reviewed, and attention is drawn to the distinct possibility that variation in the pharmaco-sensitivity of the procedure may be attributable to often extreme methodological variation between laboratories. In considering further this issue, attention is also drawn to the need to collect data under constant test conditions and to provide the minimum database necessary to reach conclusions regarding the behavioural specificity of drug action. Recent research, which has extended the conventional plus-maze scoring technique to include specific behavioural acts and postures (in particular, those relating to defensive behaviour), is described. The value of such an ethological approach to the plus-maze is then exemplified with original data that demonstrate behaviourally selective, anti-anxiety effects of the GABAA receptor agonist, muscimol (0.125–1.0 mg/kg). It is concluded that, when used appropriately, the elevated plus-maze test can be a very valuable tool in drug screening and in the study of the neurobiology of anxiety and defence. More attention to behaviour and somewhat less emphasis on test simplicity and convenience would seem to be warranted,

References (76)

  • J. Harro

    Measurement of exploratory behavior in rodents

  • C. Lee et al.

    Effects of benzodiazepine receptor antagonist, flumazenil, on murine antinociceptive and behavioural responses to the elevated plus-maze

    Neuropharmacology

    (1991)
  • R.G. Lister

    Ethologically-based animal models of anxiety disorders

    Pharmac. Ther.

    (1990)
  • R. Misslin et al.

    Does neophobia imply fear or anxiety?

  • S. Pellow et al.

    Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

    J. Neurosci. Meths

    (1985)
  • M. Reibaud et al.

    Evaluation of putative anxiolytics in the elevated plus-maze test

  • A. Rex et al.

    Effects of BOC-CCK-4 and L-365,260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze

    Neuropharmacology

    (1994)
  • R.J. Rodgers et al.

    Anxiety enhancement in the murien elevated plus-maze by immediate prior-exposure to social stressors

    Physiol. Behav.

    (1993)
  • R.J. Rodgers et al.

    Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test

    Eur. J. Pharmacol.

    (1994)
  • R.J. Rodgers et al.

    Ethopharmacological analysis of the effects of putative ‘anxiogenic’ agents in the mouse elevated plus-maze

    Pharmacol Biochem. Behav

    (1995)
  • R.J. Rodgers et al.

    Anti-anxiety and behavioural suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

    Pharmacol. Biochem. Behav.

    (1994)
  • R.J. Rodgers et al.

    Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze

    Pharmacol. Biochem. Behav.

    (1995)
  • R.J. Rodgers et al.

    Pharmacol. Biochem. Behav.

    (1994)
  • D.J. Sanger

    gABA and the behavioural effects of anxiolytic drugs

    Life Sci.

    (1985)
  • R.A. Shephard

    Neurotransmitters, anxiety and benzodiazepines: a behavioral reveiw

    Neurosci. Biobehav. Rev.

    (1986)
  • D. Treit

    Animal models for the study of anti-anxiety agents: a review

    Neurosci. Biobehav. Rev.

    (1985)
  • D. Treit et al.

    Anxiogenic stimuli in the elevated plus-maze

    Pharmacol. biochem. Behav.

    (1993)
  • R.E. Adamec

    Neuroplasticity in anxiety and defense

  • D.C. Blanchard et al.

    Risk assessment and animal models of anxiety

  • R.J. Blanchard et al.

    Anti-predator defensive behaviors in a visible burrow system

    J. Comp. Psychol.

    (1989)
  • R.J. Blanchard et al.

    Antipredator beahvior of Swiss-Webster mice in a visible burrow system

    Aggress. Behav.

    (1995)
  • R.J. Blanchard et al.

    Ethological approaches to the preclinical psychopharmacology of anxiety

  • J.C. Cole et al.

    Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against α2-adrenoceptor mediation

    Psyhopharmacology

    (1995)
  • J.C. Cole et al.

    An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze

    Behav. Pharmacol.

    (1993)
  • J.C. Cole et al.

    Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperiod

    Pshychopharmacology

    (1994)
  • J.C. Cole et al.

    Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze

    Pharmacol. Biochem. Behav.

    (1995)
  • R. Corbett et al.

    GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus-maze procedures

    Psychopharmacology

    (1991)
  • B. Costall et al.

    Use of the elevated plus-maze to assess anxiolytic potential in the rat

    Br. J. Pharmacol.

    (1989)
  • Cited by (798)

    View all citing articles on Scopus
    View full text